title: [Chemotherapy and endocrine therapy of endometrial carcinoma].
abstract: The main treatment of recurrent and advanced endometrial carcinoma are chemotherapy and/or endocrine therapy. Some of the combination chemotherapy, including Cis-platinum are useful in advanced and recurrent endometrial carcinoma, and progestational agents are available for adjuvant chemo-endocrine therapy after operation of endometrial carcinoma. Authors consider the literatures of the chemotherapy and endocrine therapy for endometrial carcinoma and describe our own cases.
authors.affiliation: Dept. of Genecol., Saitama Cancer Center Hospital.
authors.forename: T
authors.initials: T
authors.lastname: Kanuma
authors.forename: M
authors.initials: M
authors.lastname: Matsuzawa
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D045167:Progesterone Congeners / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
chemical_list: D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D013629:Tamoxifen; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin